research 5-Alpha-Reductase Inhibitors Are Associated With Reduced Frequency of COVID-19 Symptoms in Males With Androgenetic Alopecia
Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.
Search
for
Sort by
Research
690-720 / 1000+ results 
research Inhibition of SARS-CoV-2 Entry Through the ACE2/TMPRSS2 Pathway: A Promising Approach for Uncovering Early COVID-19 Drug Therapies
Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.
research Factors Associated with Anti-SARS-CoV-2 IgG Antibody Production in Patients Convalescing from COVID-19
Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.
research Efficacy of QR678 Neo Hair Growth Factor Formulation for the Treatment of Hair Loss in COVID-19-Induced Persistent Telogen Effluvium: A Prospective, Clinical, Single-Blind Study
QR678 Neo® hair growth treatment is effective for hair loss caused by Covid-19.
research Decision Letter for The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies
research Pregnancy and Postpartum Maternal Hair Cortisol Are Associated With Infant Development During the COVID-19 Pandemic
Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.
research Effects of Exposure Time to Sun on Hair Fall During Lockdown in Covid Pandemic
Quarantine increased hair fall, especially in young women, with no direct link to short sun exposure.
research Response to Letter Regarding Androgen Receptor PolyQ Alleles and COVID-19
The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.
research Whole Plant Adiantum Capillus-Veneris Linn. Extract as an Anti-COVID-19 Therapy
The extract from the plant Adiantum capillus-veneris might be used to treat COVID-19.
research Faculty Opinions Recommendation of Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients – The 'Gabrin Sign'
research Management of Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia During and After COVID-19
Doctors should adjust how they treat men with prostate-related urinary problems during and after the COVID-19 pandemic.
research Dietary Patterns, Plasma and Hair Trace Element in Ukrainian Cohort of Adults During COVID-19 Pandemic: A Cross-Sectional Study
Good nutrition and essential trace elements like zinc, selenium, and iron are important for a strong immune system and reducing COVID-19 severity.
research Raw Data from JAAD Research Letter: Androgenetic Alopecia Present in the Majority of Patients Hospitalized with COVID-19: The 'Gabrin Sign'
research Recommendations from the Pediatric Dermatology Branch, Chilean Society of Pediatrics. COVID-19 Pandemic
The document's conclusion cannot be provided because the document itself is not accessible or cannot be parsed.
research Cutaneous Signs in COVID-19 Patients: A Review
COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience
Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.
research COVID-19 Induced Telogen Effluvium
COVID-19 may cause temporary hair loss in some people.
research A Case of Acute Telogen Effluvium After SARS-CoV-2 Infection
COVID-19 may trigger sudden temporary hair loss.
research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review
COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.
research Post-SARS-CoV-2 Acute Telogen Effluvium: An Expected Complication
Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.
research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management
Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.
research Immunoreactivity of the SARS-CoV-2 Entry Proteins ACE-2 and TMPRSS-2 in Murine Models of Hormonal Manipulation, Aging, and Cardiac Injury
Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.
research Telogen Effluvium in SARS-CoV-2 Infection: Histological Aspects
COVID-19 can cause a temporary hair loss condition.
research Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019
Severe hair loss is linked to worse COVID-19 outcomes, especially in younger men.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research New-Onset and Exacerbated Skin Diseases After COVID-19 Infection: A Systematic Review
COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.
research Ultrastructural Evidence for Anagen Hair Follicle Infection with SARS-CoV-2 in Early-Onset COVID-19 Effluvium
COVID-19 may cause early hair loss by infecting hair follicles.
research Acute Telogen Effluvium in Patients Recently Infected with SARS-CoV-2
Some people who got COVID-19 experienced temporary hair loss starting around 10 weeks after infection, with many seeing improvement within about 25 days.
research Comment on: The Gabrin Sign
The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.